Understanding Membrane Dynamics and their Implications for Cancer with Correlative Optical Nanoscopy and Artificial Intelligence

Project summary

Project acronym
MEDYCONAI
Main Thematic area
E - ICT
E.3 - Advanced robotics, mechatronics and additive manufacturing technologies (3D printing, bio-printing);
ict
Secondary Thematic area
E - ICT
E.2 - Technologies, instruments and methods for software development – artificial intelligence (AI) & cloud computing;
Tertiary Thematic area
Key words
optical nanoscopy
membrane dynamics
Artificial intelligence
aneuploidy
cancer
Search
Principal investigator
Ștefan George Stanciu
Megaphone
Project promoter
UNIVERSITATEA POLITEHNICA DIN BUCURESTI
Euro
Funding
RO Research Programme - EEA Grants
Users
Partners
Oslo University Hospital
Pin 01
Location
Bucharest
Calendar
Period of implementation
2021-01-01 to 2024-04-30

Project in a nutshell

To address pending challengesin cell biology the MEDYCONAI project combined complex optical, photonic and mechatronics approaches with sophisticated machine learning methods to develop an innovative system for multimodal imaging system, INTELINANO, taking the form of a tabletop, multimodal prototype nanoscope that offers easy operation and flexibility for imaging of the structure and chemistry in both 2D and 3D. It incorporates a variety of complementary imaging techniques, operating in the farfield and near-field regimes, providing unprecedented possibilities for the label-based and label-free characterization of cells at micro- & nanoscale resolutions. 

This combination of technologies opens new avenues towards advancing the understanding on cells at nanoscopic scales. In parallel to the technical developments, the two partners implemented experiments tackling fundamental questions that revolve around cell life and fate and will continue these efforts by exploiting the vast potential of INTELINANO. Important focus has also been placed on investigating via complex imaging approaches, complementing diverse assays of distinct kind, important aspects involved in the action of theranostic nanomaterials targeting cancers. 

Alongside this main body of efforts, the advantages of micro and nanoscale imaging have been as well put to work to shed light on relevant interactions between therapeutic nanomaterials and prokaryotic cells.

Scientific results


publication
Publications
20
conference
Conferences
10



The novel correlative nanoscope developed in the project, and the implemented work on cancer cell imaging and understanding, has the potential to significantly reduce social and economic disparities by improving cancer research and treatment, enhancing research capabilities in under-resourced regions, providing socioeconomic benefits through local economic development and improved public health, and contributing to educational advancements. 

These multifaceted impacts can lead to a more equitable and prosperous society.

Socio-economic impact

The multimodal INTELINANO prototype nanoscope, offering complex advantages for imaging the structure and chemistry of biological samples and advanced materials, developed in the project, represents a valuable resource for both life and materials scientists. It allows cells biologists to probe important cell processes via diverse contrast mechanisms complementary to fluorescence, the main workhorse in cell biology, overcoming intrinsic limitations related to fluorescence labeling. 

It allows materials scientists to probe and resolve important nanomaterial-cell interactions, such as internalization routes, therapeutic mode of action, unwanted effects, etc. The open-architecture of the INTELINANO prototype is also a highly useful result for optical & photonic engineers, given that it allows easy scaling up with additional workmodes, relying on a highly flexible architecture, and being comprised of optical and opto-mechatronic components that can be easily repurposed, to test new ideas and implement potential novel workmodes. Furthermore, the project activities contributed to the development of novel (mainly cancer focused) theranostic nanomaterials, and to new body of knowledge related to nanomaterials – cells interactions. This will be of great benefit to stakeholders in nanomedicine, but also the the consortium partners, who will continue collaborative work on this topic, in partnership with teams at the forefront of nanobiomaterials. 

Research in the spotlight




[T: 0.1739, O: 133]